Marilena Vrana: The Final Day of IPPC 2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“The final day of IPPC 2026 was incredibly impactful.
The day got off to a fast start with David Osgathorp, a leading expert on professional performance and resilience from Red Bull Racing and Red Bull Technology.
His lessons learned from working with professional athletes set the tone for a dynamic and engaging panel on the next generation of leadership in the unique plasma sector.
I will be reflecting on some of these profound insights as my own career continues in this space.
The panel set the direction for how PPTA Europe can further engage and support the next generation.
Today’s final panels pushed us to think bigger about donor health and safety, as well as what it would really take to boost plasma collection in Europe.
International Plasma Protein Congress is an opportunity for ideas to turn into action, and this year truly delivered.
Already looking ahead to IPPC2027 in Barcelona, now less than a year away.
Let’s keep the momentum going!
See you on 20-21 April 2027.

More posts featuring Marilena Vrana on Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice